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Oral delivery of biopharmaceuticals has been representing an extensively active area of 
research during last decades. Part of this increasing interest comes from the superiority of this 
route over the parenteral one in terms of patients’ convenience and compliance. However, 
biopharmaceuticals are delegate materials and are liable to degradation and inactivation 
during manufacturing and transit in the GIT after administration. Several studies utilised a 
variety of nanocarriers systems to deliver those macromolecules through this route. Among 
them, hybrid nanoparticles constitute a promising approach to achieve this mission. Based on 
the physicochemical properties of the loaded drug and the required features of a platform, a 
variety of one-step and two-step methods have been employed to fabricate these hybrid 
nanocarriers. Printing technology, recently introduced to the pharmaceutical field, seems to 
have the potentiality to prepare such systems. 
This project aims the investigation of the emerging area of additive manufacturing, namely 
syringe extrusion technique and inkjet printing, for the construction of orally delivered 
peptide-loaded hybrid nanocarriers. In this study, the principles of Quality by Design and 
Design of Experiments will be exploited to investigate the process parameters and material 
attributes that affect the characteristics and the performance of the printed hybrid 
nanocarriers. The physical characteristics of the nanocarriers and the biological activity of the 
peptide will be examined. After that, the design space for the optimized response will be 
determined and verified. 
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